Saturday, April 30, 2011

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA


In continuation of my update on drugs discovery on  rheumatoid arthritis

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA..

No comments:

Post a Comment